Immediate Implant Placement With Autogenous Maxillary Tuberosity Graft in the Esthetic Zone

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City

About this trial

Immediate implant placement in the esthetic zone is often associated with buccal bone deficiency, which may compromise esthetic outcomes and long-term implant stability. Autogenous bone graft harvested from the maxillary tuberosity provides corticocancellous bone with favorable biological properties and may help reconstruct the buccal bone plate during immediate implant placement.

This prospective case series aims to evaluate the clinical and esthetic outcomes of immediate implant placement combined with autogenous maxillary tuberosity graft in the esthetic zone. The primary outcomes include buccal bone thickness measured on cone-beam computed tomography (CBCT), facial soft tissue thickness measured clinically, and the pink esthetic score (PES) after implant restoration.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 years or older

Patients requiring single implant placement in the maxillary esthetic zone

Indication for immediate implant placement following tooth extraction

Presence of a buccal bone defect requiring augmentation with an autogenous maxillary tuberosity bone graft

Disqualifiers

Uncontrolled sHistory of radiotherapy in the head and neck region ystemic diseases

History of radiotherapy in the head and neck region

Active periodontal disease or untreated oral infection

Heavy smoking (more than 10 cigarettes per day)

Trial design

Design model

Single group

Treatments tested in this trial

  • Immediate Implant Placement With Maxillary Tuberosity Autogenous Graft

    Procedure/Surgery

    Immediate implant placement in the maxillary esthetic zone combined with autogenous bone graft harvested from the maxillary tuberosity. The graft is used to reconstruct the buccal bone plate and improve peri-implant tissue stability and esthetic outcomes.

Treatment groups

15 Participants
are divided into 1 treatment group
Group A: Immediate Implant With Maxillary Tuberosity GraftExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Buccal Bone Thickness

Buccal bone thickness around the implant measured on cone-beam computed tomography (CBCT) in the mid-facial aspect of the implant site.

Time frame
6 months after implant placement

Secondary outcomes

1

Facial Soft Tissue Thickness

Facial peri-implant soft tissue thickness measured clinically at the mid-facial aspect of the implant site.

Time frame
6 months after implant placement

Other outcomes

1

Pink Esthetic Score (PES)

Esthetic evaluation of peri-implant soft tissue using the Pink Esthetic Score (PES) assessed after prosthetic restoration.

Time frame
6 months after implant placement

Sponsors and contacts

Click on the lead sponsor to view all of their trials.